University of Thessaly (UTH)
Ιολογικοί και μικροβιακοί παράγοντες ως εκλυτικό αίτιο εμφάνισης ψωρίασης και άλλων ανοσο-επαγόμενων δερματικών παθήσεων
Abstract
dc:descriptionIntroduction: Psoriasis is a chronic, immune-mediated inflammatory skin condition that affects the global population. Its pathogenesis is complex and involves interactions between genetic predisposition, environmental triggers, and immune system dysregulation. While bacterial infections—particularly streptococcal infections—have long been associated with triggering psoriasis, recent attention has shifted toward viral agents, especially those from the Herpesviridae family. Epstein-Barr Virus (EBV), a ubiquitous herpesvirus that establishes latent infection in B lymphocytes, has been linked to various autoimmune diseases, including systemic lupus erythematosus and multiple sclerosis. Several studies suggest that EBV may play a role in the onset or exacerbation of psoriasis, although the relationship remains unclear. Aim: The aim of the study was to evaluate the antibody response of psoriasis patients against various EBV antigens using Western blot analysis, compare with healthy controls, and explore associations between EBV reactivity and clinical characteristics of the disease. Material and methods: 48 patients with psoriasis (21 women, median age: 49 years) and 32 healthy controls (19 women, median age: 47 years) were tested using a Western blot assay targeting 11 EBV antigens.Results: All psoriasis patients (100%) were positive for anti-VCA antibodies, compared to 96.9% of controls (p = 0.400). Anti-EBNA-1 antibodies were significantly more prevalent in patients (97.9%) compared to HCs controls (68.8%, p < 0.001), while a significantly lower proportion of psoriasis patients showed VCA reactivity (VCA+/EA−/EBNA−) compared to controls (4.17% vs 28.13%, p = 0.002). Among the 11 antigens tested, the most frequent reactivity recognized in psoriasis patients was against p22.VCA (97.9%), p79.EBNA-1 (93.75%), and p42.VCA (56.25%). Psoriasis patients had significantly higher reactivity compared to HCs against p125.VCA, p79.EBNA-1, and p45.EAD. In addition, Psoriasis patients had a significantly higher number of reactive EBV antigens per individual compared to controls. Furthermore, psoriasis patients showed significantly higher titers against multiple EBV antigens, including p125.VCA , p93.EAR, p45.EAD, p43.EAD and p41.VCA. Finally, the presence of a greater number of reactive bands was associated with current use of bDMARDs, and another correlation was also found between positivity for EA antigens and previous use of sDMARDs. Conclusion: The findings suggest that psoriasis patients exhibit stronger and broader humoral immune responses to EBV antigens compared to healthy individuals. This includes higher frequencies of antibody reactivity, greater numbers of EBV-reactive antibodies per patient, and elevated titers against specific viral proteins. These data support the hypothesis that EBV may play a contributing role in the pathogenesis of the disease. However, further research and a higher number of patients are required to establish a causal relationship and to explore the underlying mechanisms through which EBV might influence disease activity or severity.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ntavari, Niki
- Ντάβαρη, Νίκη
Subjects
dc:subject × 11Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61706